4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-016700
President and CEO sold 3,506 shares at $3.16 ($11,079)
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-06 | Sale : show line 1 in the form | −3,506 | $3.16 | $11,079 | 820,116 | D |
| Open-market sales · 3,506 sh · avg $3.16 · $11,079 | ||||||
Loading xslF345X03/doc4.xml…